We have previously shown that prophylactic administration of native flagellin, a TLR5 agonist protein extracted from the flagella of Salmonella typhimurium, protected allo-BMT recipients both from GvHD and lethal CMV infection [8]. Here, TLR5 is linked to cytomegalovirus infection.